BioWorld

April 14, 1992

View Archived Issues

ROBERTS LICENSES PEDIATRIC DRUG FROM ORTHO

Read More

ENZON REPORTS ON BLOOD SUBSTITUTE

Read More

EPIGEN ARRANGES VEHICLE FOR CLINICAL TEST

Read More

DYNAGEN TO BEGIN PHASE II OF NICERASE

Read More

GOTTESMAN TAKES OVER GENOME PROJECT

Read More

BIOCHEM PHARMA OFFERING 3.5 MILLION SHARES

Read More

INVESTOR TO BUY TECHNICLONE SHARES

Read More

ROCHE LICENSES COMPOUNDS FROM XENOVA

Read More

ALKERMES LAUNCHES PARTNERSHIP FOR $46M

Read More